Epigenetics: An Expanding New Piece of the Stroke Puzzle
Translational Stroke Research, ISSN: 1868-601X, Vol: 2, Issue: 3, Page: 243-247
2011
- 11Citations
- 24Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations11
- Citation Indexes11
- 11
- CrossRef7
- Captures24
- Readers24
- 24
Article Description
Genome-wide association studies of stroke have revealed a polygenomic pathology in which contributions from individual genes are highly variable. This variability appears to be due at least in part to contributions from epigenetic mechanisms that fall into three main categories. The first includes mechanisms that mediate DNA methylation and attenuate gene expression. The second category includes the enzymes that add and remove acetyl groups to lysine residues in histone proteins and thereby facilitate or inhibit their dissociation for DNA with subsequent increases or decreases in gene expression, respectively. The third category includes the pathways that regulate the synthesis and action of micro-RNAs that regulate mRNA translation. Together, these epigenetic mechanisms convert environmental conditions and physiological stresses into long-term changes in gene expression and translation. Studies of epigenetic mechanisms in stoke are in their infancy but offer great promise for better understanding of stroke pathology and the potential viability of new strategies for its treatment. © 2011 Springer Science+Business Media, LLC.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=80052266670&origin=inward; http://dx.doi.org/10.1007/s12975-011-0094-0; http://www.ncbi.nlm.nih.gov/pubmed/21987632; http://link.springer.com/10.1007/s12975-011-0094-0; https://dx.doi.org/10.1007/s12975-011-0094-0; https://link.springer.com/article/10.1007/s12975-011-0094-0; http://www.springerlink.com/index/10.1007/s12975-011-0094-0; http://www.springerlink.com/index/pdf/10.1007/s12975-011-0094-0
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know